Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
PLoS One ; 13(11): e0205708, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30452459

RESUMEN

Hydration is one of the most significant issues for combat sports as athletes often use water restriction for quick weight loss before competition. It appears that alkaline water can be an effective alternative to sodium bicarbonate in preventing the effects of exercise-induced metabolic acidosis. Therefore, the main aim of the present study was to investigate, in a double blind, placebo controlled randomized study, the impact of mineral-based highly alkaline water on acid-base balance, hydration status, and anaerobic capacity. Sixteen well trained combat sport athletes (n = 16), were randomly divided into two groups; the experimental group (EG; n = 8), which ingested highly alkaline water for three weeks, and the control group (CG; n = 8), which received regular table water. Anaerobic performance was evaluated by two double 30 s Wingate tests for lower and upper limbs, respectively, with a passive rest interval of 3 minutes between the bouts of exercise. Fingertip capillary blood samples for the assessment of lactate concentration were drawn at rest and during the 3rd min of recovery. In addition, acid-base equilibrium and electrolyte status were evaluated. Urine samples were evaluated for specific gravity and pH. The results indicate that drinking alkalized water enhances hydration, improves acid-base balance and anaerobic exercise performance.


Asunto(s)
Álcalis/administración & dosificación , Suplementos Dietéticos , Bicarbonato de Sodio/administración & dosificación , Equilibrio Ácido-Base/efectos de los fármacos , Acidosis/etiología , Adulto , Atletas , Rendimiento Atlético/fisiología , Bicarbonatos/administración & dosificación , Método Doble Ciego , Ejercicio Físico/fisiología , Humanos , Ácido Láctico/metabolismo , Masculino , Resistencia Física/fisiología , Deportes/fisiología
2.
Saudi J Kidney Dis Transpl ; 29(5): 1240-1244, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30381529

RESUMEN

Vesicoureteric reflux (VUR) is the most common congenital anomaly of the urinary tract that occurs in 30%-50% of children presenting with recurrent urinary tract infections. Long-standing untreated VUR results in renal scarring and hydronephrotic changes ultimately leading to chronic renal failure and arterial hypertension. However, it may also result in diffuse tubulopathy compromising the concentrating capacity of tubules and urinary acidification defects. Renal tubular dysfunction should be considered in all children with VUR presenting with failure to thrive, rickets, bony deformity/pain, hypokalemia, and metabolic acidosis. We report such a case of a 16-year-old male adolescent who presented with rickets, failure to gain weight and height, bony pains, and muscle weakness with a history of VUR. On investigation, he was found to have normal anion gap metabolic acidosis with hypokalemia suggestive of distal renal tubular acidosis. He responded well to oral alkali and potassium replacement therapy.


Asunto(s)
Acidosis Tubular Renal/etiología , Túbulos Renales Distales , Reflujo Vesicoureteral/complicaciones , Acidosis Tubular Renal/diagnóstico por imagen , Acidosis Tubular Renal/fisiopatología , Administración Oral , Adolescente , Álcalis/administración & dosificación , Suplementos Dietéticos , Humanos , Hipopotasemia/etiología , Túbulos Renales Distales/diagnóstico por imagen , Túbulos Renales Distales/efectos de los fármacos , Túbulos Renales Distales/patología , Túbulos Renales Distales/fisiopatología , Masculino , Potasio/administración & dosificación , Bicarbonato de Sodio/administración & dosificación , Resultado del Tratamiento , Ultrasonografía , Reflujo Vesicoureteral/diagnóstico , Reflujo Vesicoureteral/fisiopatología
3.
Anesth Analg ; 126(4): 1159-1169, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29239964

RESUMEN

BACKGROUND: Tricyclic antidepressants (TCAs) are a major cause of fatal drug poisoning due to their cardiotoxicity. Alkalinization by sodium bicarbonate (NaHCO3) administration, the first-line therapy for TCA-induced cardiotoxicity, can occasionally yield insufficient efficacy in severe cases. Because most TCAs are highly lipophilic, lipid emulsion may be more effective than alkalinization. However, it remains to be determined whether lipid emulsion is more beneficial than alkalinization in reversing amitriptyline-induced cardiotoxicity. METHODS: Hemodynamic variables were recorded from in vivo guinea pig models and Langendorff-perfused hearts. Whole-cell patch-clamp experiments were conducted on enzymatically isolated ventricular cardiomyocytes to record fast sodium currents (INa). Lipid solutions were prepared using 20% Intralipid. The pH of the alkaline solution was set at 7.55. We assessed the effect of lipid emulsion on reversing amitriptyline-induced cardiotoxicity, in vivo and in vitro, compared to alkalinization. The data were evaluated by Student t test, 1-way repeated-measures analysis of variance, or analysis of covariance (covariate = amitriptyline concentration); we considered data statistically significant when P < .05. RESULTS: In the in vivo model, intervention with lipids significantly reversed the amitriptyline-induced depression of mean arterial pressure and prolongation of QRS duration on electrocardiogram more than alkalinization (mean arterial pressure, mean difference [95% confidence interval]: 19.0 mm Hg [8.5-29.4]; QRS duration, mean difference [95% confidence interval] -12.0 milliseconds [-16.1 to -7.8]). In the Langendorff experiments, perfusion with 1% and 2% lipid solutions demonstrated significant recovery in left ventricular developed pressure (LVdevP), maximum change rate of increase of LVdevP (dP/dtmax) and rate-pressure product compared with alkaline solution (LVdevP [mm Hg], alkaline 57 ± 35, 1% lipid 94 ± 12, 2% lipid 110 ± 14; dP/dtmax [mm Hg/s], alkaline 748 ± 441, 1% lipid 1502 ± 334, 2% lipid 1753 ± 389; rate-pressure product [mm Hg·beats·minute], alkaline 11,214 ± 8272, 1% lipid 19,025 ± 8427, 2% lipid 25,261 ± 4803 with analysis of covariance). Furthermore, lipid solutions (0.5%-4%) resulted in greater recovery of hemodynamic parameters at 3 µM amitriptyline. Amitriptyline inhibited INa in a dose-dependent manner: the half-maximal inhibitory concentration (IC50) was 0.39 µM. The IC50 increased to 0.75 µM in the alkaline solution, 3.2 µM in 1% lipid solution, and 6.1 µM in 2% lipid solution. Furthermore, the lipid solution attenuated the use-dependent block of sodium channels by amitriptyline more than alkaline solution. On 30 consecutive pulses at 1 Hz, the current decreased to 50.1 ± 2.1, 60.3 ± 1.9, and 90.4% ± 1.8% in standard, alkaline, and 1% lipid solution, respectively. Even 0.5% lipid solution showed greater effects than the alkaline solution in all experiments. CONCLUSIONS: Lipid emulsion significantly suppressed amitriptyline-induced INa, inhibition, which was likely related to the marked improvement in hemodynamic status observed in vivo and in isolated perfused hearts. These results suggest the superiority of lipid emulsion as the first-line therapy for TCA-induced cardiotoxicity compared to alkalinization therapy.


Asunto(s)
Equilibrio Ácido-Base/efectos de los fármacos , Álcalis/administración & dosificación , Amitriptilina , Cardiopatías/tratamiento farmacológico , Fosfolípidos/administración & dosificación , Bicarbonato de Sodio/administración & dosificación , Aceite de Soja/administración & dosificación , Potenciales de Acción/efectos de los fármacos , Animales , Presión Arterial/efectos de los fármacos , Cardiotoxicidad , Modelos Animales de Enfermedad , Emulsiones/administración & dosificación , Cobayas , Cardiopatías/sangre , Cardiopatías/fisiopatología , Frecuencia Cardíaca/efectos de los fármacos , Concentración de Iones de Hidrógeno , Infusiones Intravenosas , Preparación de Corazón Aislado , Cinética , Masculino , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Recuperación de la Función , Sodio/metabolismo , Función Ventricular Izquierda/efectos de los fármacos
4.
Int J Food Sci Nutr ; 67(7): 754-61, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27338594

RESUMEN

Western diet, high in protein-rich foods and poor in vegetables, is likely to be responsible for the development of a moderate acid excess leading to metabolism deregulation and the onset or worsening of chronic disturbances. Available findings seem to suggest that diets with high protein/vegetables ratio are likely to induce the development of calcium lithiasis, especially in predisposed subjects. Moreover, some evidence supports the hypothesis of bone metabolism worsening and enhanced bone loss following acid-genic diet consumption although available literature seems to lack direct and conclusive evidence demonstrating pathological bone loss. According to other evidences, diet-induced acidosis is likely to induce or accelerate muscle wasting or sarcopenia, especially among elderlies. Furthermore, recent epidemiological findings highlight a specific role of dietary acid load in glucose metabolism deregulation and insulin resistance. The aim of this review is to investigate the role of acid-genic diets in the development of the mentioned metabolic disorders focusing on the possible clinical improvements exerted by alkali supplementation.


Asunto(s)
Acidosis/etiología , Álcalis/administración & dosificación , Dieta Occidental/efectos adversos , Suplementos Dietéticos , Enfermedades Óseas/dietoterapia , Enfermedades Óseas/etiología , Enfermedad Crónica , Ensayos Clínicos como Asunto , Proteínas en la Dieta/administración & dosificación , Humanos , Resistencia a la Insulina , Sarcopenia/dietoterapia , Sarcopenia/etiología , Cálculos Urinarios/dietoterapia , Cálculos Urinarios/etiología , Verduras
5.
J Clin Endocrinol Metab ; 97(12): 4789-97, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23027921

RESUMEN

High sodium chloride (NaCl) intake can induce low-grade metabolic acidosis (LGMA) and may thus influence bone and protein metabolism. We hypothesized that oral potassium bicarbonate (KHCO(3)) supplementation may compensate for NaCl-induced, LGMA-associated bone resorption and protein losses. Eight healthy male subjects participated in a randomized trial with a crossover design. Each of two study campaigns consisted of 5 d of dietary and environmental adaptation followed by 10 d of intervention and 1.5 d of recovery. In one study campaign, 90 mmol KHCO(3)/d were supplemented to counteract NaCl-induced LGMA, whereas the other campaign served as a control with only high NaCl intake. When KHCO(3) was ingested during high NaCl intake, postprandial buffer capacity ([HCO(3)(-)]) increased (P = 0.002). Concomitantly, urinary excretion of free potentially bioactive glucocorticoids [urinary free cortisol (UFF) and urinary free cortisone (UFE)] was reduced by 14% [∑(UFF,UFE); P = 0.024]. Urinary excretion of calcium and bone resorption marker N-terminal telopeptide of type I collagen was reduced by 12 and 8%, respectively (calcium, P = 0.047; N-terminal bone collagen telopeptide, P = 0.044). There was a trend of declining net protein catabolism when high NaCl was combined with KHCO(3) (P = 0.052). We conclude that during high salt intake, the KHCO(3)-induced postprandial shift to a more alkaline state reduces metabolic stress. This leads to decreased bone resorption and protein degradation, which in turn might initiate an anticatabolic state for the musculoskeletal system in the long run.


Asunto(s)
Bicarbonatos/farmacología , Resorción Ósea/etiología , Resorción Ósea/prevención & control , Compuestos de Potasio/farmacología , Proteínas/metabolismo , Cloruro de Sodio Dietético/efectos adversos , Síndrome Debilitante/etiología , Síndrome Debilitante/prevención & control , Adulto , Álcalis/administración & dosificación , Álcalis/farmacología , Álcalis/uso terapéutico , Bicarbonatos/administración & dosificación , Bicarbonatos/uso terapéutico , Huesos/efectos de los fármacos , Huesos/metabolismo , Estudios Cruzados , Suplementos Dietéticos , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Humanos , Masculino , Modelos Biológicos , Compuestos de Potasio/administración & dosificación , Compuestos de Potasio/uso terapéutico , Proteínas/efectos de los fármacos , Sales (Química)/administración & dosificación , Sales (Química)/farmacología , Sales (Química)/uso terapéutico , Adulto Joven
6.
In Vivo ; 24(5): 735-43, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20952742

RESUMEN

Previous studies have shown anti-inflammatory potential of alkaline extract of the leaves of Sasa senanensis Rehder (SE). The aim of the present study was to clarity the molecular entity of SE, using various fractionation methods. SE inhibited the production of nitric oxide (NO), but not tumour necrosis factor-α by lipopolysaccharide (LPS)-stimulated mouse macrophage-like cells. Lignin carbohydrate complex prepared from SE inhibited the NO production to a comparable extent with SE, whereas chlorophyllin was more active. On successive extraction with organic solvents, nearly 90% of SE components, including chlorophyllin, were recovered from the aqueous layer. Anti-HIV activity of SE was comparable with that of lignin-carbohydrate complex, and much higher than that of chlorophyllin and n-butanol extract fractions. The CYP3A inhibitory activity of SE was significantly lower than that of grapefruit juice and chlorophyllin. Oral administration of SE slightly reduced the number of oral bacteria. When SE was applied to HPLC, nearly 70% of SE components were eluted as a single peak. These data suggest that multiple components of SE may be associated with each other in the native state or after extraction with alkaline solution.


Asunto(s)
Álcalis/administración & dosificación , Antiinflamatorios/administración & dosificación , Macrófagos/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Sasa/química , Estomatitis/tratamiento farmacológico , Animales , Infecciones por Bacteroidaceae/tratamiento farmacológico , Infecciones por Bacteroidaceae/inmunología , Infecciones por Bacteroidaceae/microbiología , Línea Celular , Clorofilidas/farmacología , Citrus paradisi/química , Infecciones por VIH/tratamiento farmacológico , Humanos , Lignina/farmacología , Lipopolisacáridos/farmacología , Macrófagos/citología , Macrófagos/metabolismo , Masculino , Ratones , Microsomas Hepáticos/efectos de los fármacos , Óxido Nítrico/metabolismo , Porphyromonas gingivalis/efectos de los fármacos , Porphyromonas gingivalis/crecimiento & desarrollo , Ratas , Estomatitis/inmunología , Estomatitis/microbiología , Factor de Necrosis Tumoral alfa/metabolismo
7.
J Urol ; 183(6): 2419-23, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20403610

RESUMEN

PURPOSE: Citrate is a known inhibitor of calcium stone formation. Dietary citrate and alkali intake may have an effect on citraturia. Increasing alkali intake also increases urine pH, which can help prevent uric acid stones. We determined citrate, malate and total alkali concentrations in commonly consumed diet sodas to help direct dietary recommendations in patients with hypocitraturic calcium or uric acid nephrolithiasis. MATERIALS AND METHODS: Citrate and malate were measured in a lemonade beverage commonly used to treat hypocitraturic calcium nephrolithiasis and in 15 diet sodas. Anions were measured by ion chromatography. The pH of each beverage was measured to allow calculation of the unprotonated anion concentration using the known pK of citric and malic acid. Total alkali equivalents were calculated for each beverage. Statistical analysis was done using Pearson's correlation coefficient. RESULTS: Several sodas contained an amount of citrate equal to or greater than that of alkali and total alkali as a lemonade beverage commonly used to treat hypocitraturic calcium nephrolithiasis (6.30 mEq/l citrate as alkali and 6.30 as total alkali). These sodas were Diet Sunkist Orange, Diet 7Up, Sprite Zero, Diet Canada Dry Ginger Ale, Sierra Mist Free, Diet Orange Crush, Fresca and Diet Mountain Dew. Colas, including Caffeine Free Diet Coke, Coke Zero, Caffeine Free Diet Pepsi and Diet Coke with Lime, had the lowest total alkali (less than 1.0 mEq/l). There was no significant correlation between beverage pH and total alkali content. CONCLUSIONS: Several commonly consumed diet sodas contain moderate amounts of citrate as alkali and total alkali. This information is helpful for dietary recommendations in patients with calcium nephrolithiasis, specifically those with hypocitraturia. It may also be useful in patients with low urine pH and uric acid stones. Beverage malate content is also important since malate ingestion increases the total alkali delivered, which in turn augments citraturia and increases urine pH.


Asunto(s)
Álcalis/administración & dosificación , Bebidas Gaseosas/análisis , Citratos/análisis , Malatos/análisis , Nefrolitiasis/dietoterapia , Humanos
8.
J Biol Regul Homeost Agents ; 22(4): 225-31, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19036224

RESUMEN

This study aims to determine the effects of a high protein diet and alkaline supplementation on bone metabolic turnover in rats. Eight-week-old male Sprague-Dawley rats were investigated by bone status, including bone mineral density (BMD) and biomechanical markers from blood and urine. Thirty rats were randomly divided into three groups and treated for 8 weeks as follows: baseline control group (n. 10, C), high-protein supplemented diet group (n. 10, chronic acidosis, CA group) and supplemented chronic acidosis (n.10, SCA). Diet-treated rats were fed an acidic high-protein diet and the supplementation consisted in a modified alkaline formula (Basenpulver, NaMed, Italy). At the end of the experimental period, the rats were sacrificed, blood samples were drawn and femur and tibia were removed for analysis of bone mineral density (BMD) by dual energy X-ray absorptiometry (DEXA). In the CA group, 24-hour urinary calcium (Ca) and phosphorus (P) excretion were increased 2.1-fold (p<0.05 vs normal diet controls) as well as kidney weight. However, serum Ca and P concentration, as well as urinary Dpd excretion were not significantly changed. Femural and tibial BMD was significantly decreased in the CA group (p<0.05), but alkaline supplementation prevented such phenomenon (p<0.05 vs CA). These results suggest that blood Ca and P concentrations in chronic acidosis condition during the 12-week supplementation might be maintained by hypercalciuria and hyperphosphaturia at the expenses of bone structure. However, modified alkaline supplementation is able to prevent such derangements.


Asunto(s)
Álcalis/administración & dosificación , Remodelación Ósea/efectos de los fármacos , Huesos/efectos de los fármacos , Huesos/metabolismo , Acidosis/metabolismo , Alcalosis/metabolismo , Animales , Fenómenos Biomecánicos , Densidad Ósea/efectos de los fármacos , Remodelación Ósea/fisiología , Calcio/sangre , Proteínas en la Dieta/administración & dosificación , Suplementos Dietéticos , Masculino , Fósforo/sangre , Ratas , Ratas Sprague-Dawley
9.
Ther Umsch ; 63(9): 601-7, 2006 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-17048176

RESUMEN

Intrinsic defects in tubular transport mechanisms of the kidney may cause impairment of urinary acidification or a loss of base equivalents, thereby inducing systemic metabolic acidosis. Different types of this disorder termed renal tubular acidosis (RTA) can be distinguished based on the localization of the disturbance along the nephron (proximal vs. distal) and their association with potassium transport (hypo-/hyperkalemic). Except for the proximal type RTA results in positive acid balance and negatively impacts on bone metabolism and the formation of kidney stones. The diagnosis is based on analysis of acid/base status, urinary pH and determination of ammonium excretion after an oral acid load. Both functional defects of specific tubular transport mechanisms and global impairment of renal tubular function can be causative of RTA. Their therapy is based on treatment of the primary disease process and correction of acidosis by alkali supplementation.


Asunto(s)
Acidosis Tubular Renal/diagnóstico , Acidosis Tubular Renal/orina , Álcalis/administración & dosificación , Amoníaco/orina , Acidosis Tubular Renal/tratamiento farmacológico , Acidosis Tubular Renal/fisiopatología , Administración Oral , Diagnóstico Diferencial , Humanos , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en Medicina
10.
Clin Vaccine Immunol ; 13(11): 1255-66, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16943344

RESUMEN

Previous studies have shown that the anionic alkali mineral complex BARODON has an immunoenhancing effect on pigs as an adjuvant and as a nonspecific immunostimulant. Likewise, the equine immune system has been defined with various monoclonal antibodies specific to equine leukocyte differentiation antigens to determine the possibility of enhancing equine resistance to respiratory diseases and promoting other immunostimulatory effects with the application of BARODON. Compared with the control group, after 3 weeks of treatment, BARODON-treated groups showed higher proportions of cells (P < 0.05) expressing major histocompatibility complex class II and CD2, CD4(+), CD4(+) CD25(+), CD8(+), and CD8(+) CD25(+) T lymphocytes, dendritic cells, and surface immunoglobulin M(+) B lymphocytes in peripheral blood, as well as enhanced cell proliferative responses with phytohemagglutinin and increased phagocytic activity against Streptococcus equi and Staphylococcus aureus strains with high antibiotic resistance, the bacteria frequently identified as etiologic agents of equine respiratory diseases at the Seoul Race Park in Seoul, Korea. This study shows that BARODON may act as an immunostimulator and can be an effective alternative to antimicrobial feed additives for nonspecific improvements in equine immune responses, particularly against respiratory diseases.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Álcalis/inmunología , Aniones/inmunología , Activación de Linfocitos/inmunología , Linfocitos/inmunología , Minerales/inmunología , Álcalis/administración & dosificación , Alimentación Animal , Animales , Aniones/administración & dosificación , Proliferación Celular , Células Cultivadas , Caballos , Subgrupos Linfocitarios/inmunología , Linfocitos/citología , Minerales/administración & dosificación , Soluciones
11.
Fa Yi Xue Za Zhi ; 20(3): 183-4, 2004.
Artículo en Chino | MEDLINE | ID: mdl-15495815

RESUMEN

Because of its officinal value, strychnos is widely used by clinic and individual. Since toxic dose and therapeutic dose are very close, strychnos poisoning cases are frequently reported. In this paper the chemical component, toxic dose, mechanisms of toxicity, poisoning symptom and pathological changes after strychnos poisoning are reviewed.


Asunto(s)
Estricnina/envenenamiento , Strychnos/toxicidad , Álcalis/administración & dosificación , Álcalis/envenenamiento , Animales , Sistema Nervioso Central/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Medicina Legal , Humanos , Sistema Inmunológico/efectos de los fármacos , Dosificación Letal Mediana , Plantas Medicinales/química , Semillas/química , Estricnina/administración & dosificación , Strychnos/química , Strychnos/envenenamiento
12.
Am J Physiol Renal Physiol ; 282(6): F1049-55, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11997321

RESUMEN

Our objective was to describe the process of alkali disposal in rats. Balance studies were performed while incremental loads of alkali were given to rats fed a low-alkali diet or their usual alkaline ash diet. Control groups received equimolar NaCl or KCl. Virtually all of the alkali was eliminated within 24 h when the dose exceeded 750 micromol. The most sensitive response to alkali input was a decline in the excretion of NH(4)(+). The next level of response was to increase the excretion of unmeasured anions; this rise was quantitatively the most important process in eliminating alkali. The maximum excretion of citrate was approximately 70% of its filtered load. An even higher alkali load augmented the excretion of 2-oxoglutarate to >400% of its filtered load. Only with the largest alkali load did bicarbonaturia become quantitatively important. We conclude that renal mechanisms eliminate alkali while minimizing bicarbonaturia. This provides a way of limiting changes in urine pH without sacrificing acid-base balance, a process that might lessen the risk of kidney stone formation.


Asunto(s)
Equilibrio Ácido-Base/fisiología , Álcalis/metabolismo , Álcalis/farmacocinética , Administración Oral , Álcalis/administración & dosificación , Animales , Aniones/metabolismo , Bicarbonatos/metabolismo , Cationes/metabolismo , Ácido Cítrico/metabolismo , Ácido Cítrico/orina , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Concentración de Iones de Hidrógeno , Inyecciones Intraperitoneales , Ácidos Cetoglutáricos/metabolismo , Riñón/fisiología , Masculino , Cloruro de Potasio/administración & dosificación , Compuestos de Amonio Cuaternario/metabolismo , Ratas , Ratas Wistar , Cloruro de Sodio/administración & dosificación
13.
Osteoporos Int ; 12(6): 493-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11446566

RESUMEN

The urine-acidifying properties of food constituents depend on their content of non-oxidizable acids or precursors. Acidifying constituents such as animal proteins may negatively affect calcium metabolism and accelerate bone resorption, thus representing an aggravating factor for osteoporosis. This four-period, double-crossover study investigated whether a diet intervention specifically focused on acid load could modify calcium metabolism in humans. Eight healthy volunteers underwent a four-day metabolic preparation with two types of diets, one rich in acid ash-forming nutrients, and one providing base-forming nutrients (including bicarbonate-rich mineral water), both having similar contents of calcium, phosphate, sodium, proteins and calories. On the fourth day, a single oral dose of 1 g calcium was given, either as carbonate or as gluconolactate. Serial blood and urine samples revealed that the diet affected blood pH (average difference 0.014, p=0.002) and urine pH (average difference 1.02, p<0.0001) in the expected direction, but had no influence on the absorption of the calcium supplement. The acid-forming diet increased urinary calcium excretion by 74% when compared with the base-forming diet (p<0.0001), both at baseline and after the oral calcium load, and C-telopeptide excretion by 19% (p=0.01), suggesting a skeletal origin for the excess calcium output. This observation confirms that renally excreted acids derived from food influence calcium metabolism, and that alkalizing nutrients inhibit bone resorption. Further studies are needed to determine the clinical impact of dietary counseling for avoiding diet acids as a preventive measure against osteoporosis.


Asunto(s)
Ácidos/farmacología , Álcalis/farmacología , Huesos/metabolismo , Calcio/metabolismo , Osteoporosis/dietoterapia , Ácidos/administración & dosificación , Adulto , Álcalis/administración & dosificación , Bicarbonatos/uso terapéutico , Colágeno/orina , Colágeno Tipo I , Dieta , Humanos , Concentración de Iones de Hidrógeno , Masculino , Osteoporosis/metabolismo , Osteoporosis/prevención & control , Péptidos/orina
14.
J Endod ; 26(11): 665-7, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11469297

RESUMEN

Alkalinizing action on root dentin was investigated by treating the enlarged root canals of a total of 120 extracted teeth for 24 h, 3 days, or 7 days with either gutta-percha points (size 40) containing calcium hydroxide or an equivalent quantity of aqueous calcium hydroxide suspension. After splitting the teeth longitudinally the pH of the dentin was determined using a pH microelectrode in small cavities at each of four set measuring points. The gutta-percha points were unable to alkalinize the root dentin over a period of 7 days. Clear, rapid, and prolonged alkalinization of the dentin extending through to the root surface was achieved, however, with the aqueous calcium hydroxide suspension.


Asunto(s)
Antiinfecciosos Locales/uso terapéutico , Hidróxido de Calcio/uso terapéutico , Dentina/fisiopatología , Gutapercha/uso terapéutico , Materiales de Obturación del Conducto Radicular/uso terapéutico , Raíz del Diente/fisiopatología , Álcalis/administración & dosificación , Álcalis/uso terapéutico , Análisis de Varianza , Antiinfecciosos Locales/administración & dosificación , Hidróxido de Calcio/administración & dosificación , Humanos , Concentración de Iones de Hidrógeno , Microelectrodos , Preparación del Conducto Radicular , Suspensiones , Factores de Tiempo , Agua
15.
Plant Foods Hum Nutr ; 40(2): 99-105, 1990 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2385577

RESUMEN

The effect of treatment and supplementary value of corn (C) or crayfish (CR) on the protein quality of breadfruit (Treculia Africana) flours were studied in eighteen young rats. The 70:30 or 70:15:15 (Protein basis) combinations of breadfruit flours and corn or crayfish or both provided 1.6 g N/100 g diet for the 35 day study. The addition of 'akanwu' to the cooking water reduced cooking time and crude protein and saved fuel. The addition of 'akanwu' and replacement of CR with C was not beneficial as judged by the parameters tested except for the wt. gain and PER. On the other hand, when crayfish was the only source of supplementary protein (30%) to breadfruit cooked without 'akanwu' there were increases in all parameters tested over those with added 'akanwu' except for the N intake, wt. gain, and PER. These results appear to suggest that addition of 'akanwu' to TA was detrimental to its protein utilization and that TA appears to be an economic source of N in areas where it is a staple. Based on the results of this study, one would suggest that the use of 'akanwu' as a tenderizer should be seriously looked into before further use.


Asunto(s)
Álcalis/administración & dosificación , Astacoidea , Manipulación de Alimentos/métodos , Valor Nutritivo , Zea mays , Animales , Proteínas en la Dieta/metabolismo , Grano Comestible/metabolismo , Masculino , Nigeria , Proteínas de Vegetales Comestibles/metabolismo , Ratas , Ratas Endogámicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA